Skip to Navigation Skip to Search Skip to Content
Search All Centers

How Should Patients Manage CLL and Diabetes?

Read Transcript Download/Print Transcript
View next

Published on April 8, 2019

Patient Power community member Grant writes in, “Is there any advice for me going forward with a double diagnosis of diabetes and chronic lymphocytic leukemia (CLL)?” During this Ask the Expert segment, guest CLL expert Dr. Jeff Sharman, from The US Oncology Network, responds by giving recommendations for monitoring disease behavior and receiving treatment for both conditions. Dr. Sharman discusses potential treatment interactions and explains how CLL mutational status can impact care. 

This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc. and Pharmacyclics for their support.


Transcript | How Should Patients Manage CLL and Diabetes?

In contrast, somebody with an unmutated 17p-deleted CLL, it's the CLL that's going to be more dangerous.  Fortunately, the treatment interactions don't overlap all that much.  Sometimes with chemoimmunotherapy we give steroids, and that can be problematic for patients with diabetes, but I would manage them by and large independently.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View next